Satellite Banner
Technology Networks Header
Tuesday, September 02, 2014
 
Register | Sign in
Home Page>Products
  Product News
New Data Using EKF PointMan™ Technology
Tuesday, July 22, 2014
New data suggest the possibility of a simple blood test for cancers.

Asylum Research Opens an AFM Demonstration Lab in Mumbai, India
Tuesday, July 22, 2014
New lab to help researchers choose the best AFM for their research.

ChIP Sequencing Kit for Next Generation Sequencing
Tuesday, July 22, 2014
Company extends the benefits of their Chromatrap® solid state ChIP technology.

ZEISS Presents New Correlative Workflows for M&M 2014
Tuesday, July 22, 2014
FIB-SEM, X-ray and correlative workflows showcased at M&M 2014.

High Performance Multi-Position Reaction Block
Tuesday, July 22, 2014
DrySyn MULTI heating blocks create a safer, cleaner and more efficient working environment.

The Hiden EQP Plasma Diagnostic with On-board MCA
Tuesday, July 22, 2014
A pure research tool specifically derived and enhanced for the plasma researcher.

Reaction Monitoring Experiments for Spinsolve Benchtop NMR Spectrometers
Tuesday, July 22, 2014
Magritek have demonstrated the use of their spectrometer to perform and monitor chemical reactions on-line.

Researchers at UCF Automate Biodiesel Production Using In-line Digital Viscometer
Saturday, July 19, 2014
Researchers use VISCOpro 1600 viscometer to monitor the viscosity of the glycerol.

PAC Releases New Lab Instrument Data Integration Software, IRIS
Saturday, July 19, 2014
IRIS provides innovative results management and reporting software for PAC laboratory instruments.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 10435
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv